Tumor News and Research

RSS

FDA approves first targeted cancer treatment based on basket study

The US Food and Drug Administration has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD).

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

Italian researchers have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC).

7 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

Researchers discover how traffic jam in intracellular sorting can cause tumor development

For tissues to cooperate and perform normal functions, cells need to know which way is up. When cells lose track of their orientation, they can start to grow out of control, and develop into cancer.

6 Nov 2017

Biologics do not raise risk of second cancer diagnosis in RA patients

Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting.

6 Nov 2017

Pioneering research to grow mini bowel cancer tumor models in the lab

Charity Cancer Research UK has awarded the University of Birmingham £1.5 million to fund a five-year research program aimed at finding new treatments for bowel cancer.

6 Nov 2017

Pre-menopausal women with advanced breast cancer unnecessarily excluded from clinical trials

Pre-menopausal women with the most common type of advanced breast cancer are usually excluded from medical research unnecessarily, according to an expert panel at the Advanced Breast Cancer Fourth International Consensus Conference.

6 Nov 2017

Four main genes linked to survival of pancreatic cancer patients

Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in JAMA Oncology.

3 Nov 2017

Gut bacteria can influence how cancer responds to immunotherapy

Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve treatment, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the journal Science.

2 Nov 2017

Researchers develop new, three-step system to eliminate colorectal cancer

Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.

2 Nov 2017

Preclinical studies show effectiveness of targeted therapy for glioblastoma

The targeted therapy onalespib has shown effectiveness in preclinical studies of glioblastoma by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

2 Nov 2017

Dinosaur extinction metal can be used to kill cancer cells

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international collaboration between the University of Warwick and Sun Yat-Sen University in China.

2 Nov 2017

FDA issues warning letters to companies illegally selling products that claim to cure cancer

As part of the U.S. Food and Drug Administration's ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes.

2 Nov 2017

Discovery of genetic markers could guide individualized treatments for advanced prostate cancer

Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer.

2 Nov 2017

FDA warning on miracle marijuana cures for cancer

Yesterday, 1st November 2017, the U.S. Food and Drug Administration, FDA, released a statement warning the general public against fraudulent claims regarding marijuana based cancer cures. The FDA has also issued warnings in writing to four companies that are selling such products online illegally. These products are being advertised as miracle cures for cancers and several serious conditions.

2 Nov 2017

Breast cancer adjuvant treatment discordance linked to general distrust in healthcare system

Nearly one-third of women with breast cancer went against their doctor's advice and chose not to begin or complete the recommended adjuvant anti-cancer therapy to kill residual tumor cells following surgery, according to a study led by a Johns Hopkins Bloomberg School of Public Health researcher.

1 Nov 2017

Researchers show how changes along lining of mammary ducts can lead to breast cancer

Breast cancer researchers have mapped early genetic alterations in normal-looking cells at various distances from primary tumors to show how changes along the lining of mammary ducts can lead to disease.

1 Nov 2017

PARP inhibitors may have efficacy in selected TNBC patients outside of germline BRCA mutation

The investigational PARP inhibitor talazoparib caused regression of patient-derived xenografts (PDXs) of triple-negative breast cancers (TNBC) that had BRCA mutations and also those that did not have BRCA mutations but had other alterations in DNA damage-repair pathways.

1 Nov 2017

Starving childhood brain tumor of amino acid could improve effect of chemotherapy, study shows

Starving a childhood brain tumor of the amino acid glutamine could improve the effect of chemotherapy, according to an early study led by Queen Mary University of London and funded by Children with Cancer UK and the Medical Research Council.

1 Nov 2017

Tumor News and Research

FDA approves first targeted cancer treatment based on basket study

FDA grants approval to first treatment for rare blood cancer

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

FDA approves new drug Zelboraf for Erdheim-Chester disease

Researchers discover how traffic jam in intracellular sorting can cause tumor development

Biologics do not raise risk of second cancer diagnosis in RA patients

Pioneering research to grow mini bowel cancer tumor models in the lab

Pre-menopausal women with advanced breast cancer unnecessarily excluded from clinical trials

Four main genes linked to survival of pancreatic cancer patients

Gut bacteria can influence how cancer responds to immunotherapy

Researchers develop new, three-step system to eliminate colorectal cancer

Preclinical studies show effectiveness of targeted therapy for glioblastoma

Dinosaur extinction metal can be used to kill cancer cells

FDA issues warning letters to companies illegally selling products that claim to cure cancer

Discovery of genetic markers could guide individualized treatments for advanced prostate cancer

FDA warning on miracle marijuana cures for cancer

Breast cancer adjuvant treatment discordance linked to general distrust in healthcare system

Researchers show how changes along lining of mammary ducts can lead to breast cancer

PARP inhibitors may have efficacy in selected TNBC patients outside of germline BRCA mutation

Starving childhood brain tumor of amino acid could improve effect of chemotherapy, study shows

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News